Applying Precision Medicine to the Treatment of Hematologic Diseases
April 8, 2017 — Boston, MA
Tufts University School of Medicine
The proposed activity will highlight the most recent advances in personalizing treatment in various hematologic diseases such as amyloidosis, multiple myeloma, sickle cell anemia, chronic lymphocytic leukemia, myelodysplastic syndrome, B-cell lymphomas and Hodgkin lymphoma. The role of novel therapies such as small molecules and natural killer cells in precision medicine will also be discussed. Overall, the proposed educational agenda will enable attendees to remain abreast of and integrate critical updates in precision medicine for improved treatment and management of hematologic diseases.